Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

M) that DNI Ratcliffe's "assessment that Iran was active" in attempting to interfere in the US election "alongside Russia quickly raised eyebrows." Tabatabai writes it is "unlikely that Iran's primary goal was to hurt Trump's campaign or boost his challenger." Iran's "main goal" is instead "to exacerbate

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

M) that DNI Ratcliffe's "assessment that Iran was active" in attempting to interfere in the US election "alongside Russia quickly raised eyebrows." Tabatabai writes it is "unlikely that Iran's primary goal was to hurt Trump's campaign or boost his challenger." Iran's "main goal" is instead "to exacerbate

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

M) that DNI Ratcliffe's "assessment that Iran was active" in attempting to interfere in the US election "alongside Russia quickly raised eyebrows." Tabatabai writes it is "unlikely that Iran's primary goal was to hurt Trump's campaign or boost his challenger." Iran's "main goal" is instead "to exacerbate